Relay Therapeutics (RLAY) Institutional Ownership $3.56 -0.13 (-3.41%) As of 10:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Relay Therapeutics (NASDAQ:RLAY)CurrentInstitutional OwnershipPercentage96.98%Number ofInstitutional Buyers(last 12 months)150TotalInstitutional Inflows(last 12 months)$283.78MNumber ofInstitutional Sellers(last 12 months)57TotalInstitutional Outflows(last 12 months)$64.51M Get RLAY Insider Trade Alerts Want to know when executives and insiders are buying or selling Relay Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RLAY Institutional Buying and Selling by Quarter Relay Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Captrust Financial Advisors14,111$49K0.0%N/A0.008% 8/15/2025 Rafferty Asset Management LLC181,957$630K0.0%-11.3%0.106% 8/15/2025 Man Group plc298,510$1.03M0.0%+45.1%0.173% 8/15/2025 Engineers Gate Manager LP38,719$134K0.0%+31.5%0.022% 8/15/2025 BNP Paribas Financial Markets35,441$123K0.0%+90.6%0.021% 8/15/2025 Boothbay Fund Management LLC222,987$772K0.0%-1.7%0.129% 8/15/2025 Bellevue Group AG8,230,870$28.48M0.6%+11.6%4.774% 8/15/2025 Bank of America Corp DE1,320,130$4.57M0.0%+138.1%0.766% 8/15/2025 Ameriprise Financial Inc.410,896$1.42M0.0%+10.4%0.238% 8/15/2025 AQR Capital Management LLC1,083,465$3.75M0.0%+196.9%0.628% Get the Latest News and Ratings for RLAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 MPM Bioimpact LLC2,282,680$7.90M1.4%-0.6%1.324% 8/14/2025 Commodore Capital LP13,350,000$46.19M3.3%N/A7.743% 8/14/2025 Raymond James Financial Inc.190,488$659K0.0%+3.2%0.110% 8/14/2025 TFG Asset Management GP Ltd699,000$2.42M0.4%+12.9%0.405% 8/14/2025 The Manufacturers Life Insurance Company 212,126$734K0.0%+3.2%0.123% 8/14/2025 Sei Investments Co.25,630$89K0.0%N/A0.015% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 127,036$440K0.0%-66.8%0.074% 8/14/2025 HighVista Strategies LLC149,701$518K0.2%N/A0.087% 8/14/2025 Diadema Partners LP43,616$151K0.0%-92.2%0.025% 8/14/2025 Cerity Partners LLC14,833$51K0.0%N/A0.009% 8/14/2025 Federated Hermes Inc.71,217$246K0.0%-26.1%0.041% 8/13/2025 Jump Financial LLC15,301$53K0.0%N/A0.009% 8/13/2025 Cresset Asset Management LLC37,084$128K0.0%+26.2%0.022% 8/13/2025 Tema Etfs LLC97,150$336K0.1%+9.0%0.056% 8/13/2025 Marshall Wace LLP51,698$179K0.0%N/A0.030% 8/13/2025 Invesco Ltd.273,383$946K0.0%+47.9%0.159% 8/13/2025 Virtus Investment Advisers LLC27,256$94K0.0%-20.6%0.016% 8/13/2025 Norges Bank835,874$2.89M0.0%N/A0.485% 8/13/2025 Quadrature Capital Ltd13,496$47K0.0%N/A0.008% 8/13/2025 Hsbc Holdings PLC104,257$352K0.0%-10.4%0.060% 8/13/2025 Quadrant Capital Group LLC11,791$41K0.0%+245.1%0.007% 8/13/2025 Russell Investments Group Ltd.20,109$70K0.0%-49.1%0.012% 8/12/2025 XTX Topco Ltd241,230$835K0.0%+201.9%0.140% 8/12/2025 Prudential Financial Inc.358,225$1.24M0.0%-8.9%0.208% 8/12/2025 American Century Companies Inc.349,420$1.21M0.0%+13.2%0.203% 8/12/2025 Rhumbline Advisers221,853$768K0.0%+27.4%0.129% 8/12/2025 Franklin Resources Inc.394,122$1.36M0.0%+130.4%0.229% 8/12/2025 Legal & General Group Plc112,316$389K0.0%-13.1%0.065% 8/12/2025 JPMorgan Chase & Co.4,338,403$15.01M0.0%-11.6%2.516% 8/12/2025 Dynamic Technology Lab Private Ltd16,935$59K0.0%-15.6%0.010% Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged.8/11/2025 Persistent Asset Partners Ltd10,280$36K0.0%-89.8%0.006% 8/8/2025 Intech Investment Management LLC54,243$188K0.0%-33.4%0.032% 8/8/2025 Creative Planning72,618$251K0.0%+214.1%0.042% 8/8/2025 Police & Firemen s Retirement System of New Jersey32,373$112K0.0%+38.3%0.019% 8/8/2025 Geode Capital Management LLC3,229,666$11.18M0.0%+5.2%1.884% 8/8/2025 Quinn Opportunity Partners LLC10,000$35K0.0%N/A0.006% 8/7/2025 Profund Advisors LLC38,623$134K0.0%-10.0%0.023% 8/7/2025 Acadian Asset Management LLC794,619$2.75M0.0%+16.5%0.463% 8/7/2025 Los Angeles Capital Management LLC68,615$237K0.0%+5.0%0.040% 8/6/2025 Savant Capital LLC168,447$583K0.0%+113.7%0.098% 8/5/2025 Bank of Montreal Can55,174$191K0.0%+73.6%0.032% 8/1/2025 May Hill Capital LLC10,914$38K0.0%N/A0.006% 7/31/2025 Focus Partners Advisor Solutions LLC11,162$39K0.0%N/A0.007% 7/30/2025 FNY Investment Advisers LLC10,000$34K0.0%+100.0%0.006% 7/30/2025 Private Capital Advisors Inc.441,739$1.53M0.2%+341.7%0.258% 7/30/2025 DekaBank Deutsche Girozentrale60,000$208K0.0%-13.0%0.035% 7/28/2025 TD Asset Management Inc99,056$343K0.0%-36.7%0.058% 7/25/2025 Allspring Global Investments Holdings LLC60,331$212K0.0%-5.1%0.035% 7/25/2025 CWM LLC56,993$197K0.0%+181.2%0.033% 7/25/2025 Vanguard Personalized Indexing Management LLC25,792$89K0.0%+86.9%0.015% 7/21/2025 111 Capital24,911$86K0.0%N/A0.015% 7/11/2025 Farther Finance Advisors LLC16,702$58K0.0%+8,553.9%0.010% 7/10/2025 Wealth Enhancement Advisory Services LLC40,983$149K0.0%+164.9%0.024% 7/9/2025 Pallas Capital Advisors LLC24,758$86K0.0%N/A0.014% 6/27/2025 Goldman Sachs Group Inc.2,077,995$5.44M0.0%-23.2%1.212% 6/18/2025 Voya Investment Management LLC34,035$89K0.0%-79.0%0.020% 5/21/2025 Acadian Asset Management LLC682,028$1.79M0.0%+2,256.1%0.398% 5/19/2025 Jane Street Group LLC111,472$292K0.0%+47.6%0.065% 5/16/2025 Woodline Partners LP1,518,561$3.98M0.0%+448.4%0.886% 5/16/2025 Goldman Sachs Group Inc.2,077,995$5.44M0.0%-23.2%1.212% 5/16/2025 Dynamic Technology Lab Private Ltd20,067$53K0.0%N/A0.012% 5/16/2025 Parkman Healthcare Partners LLC188,052$493K0.1%-62.4%0.110% 5/16/2025 Murchinson Ltd.10,000$26K0.0%N/A0.006% 5/16/2025 Millennium Management LLC2,942,875$7.71M0.0%+14.6%1.717% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.84,069$221K0.0%+6.6%0.049% 5/16/2025 AQR Capital Management LLC364,946$956K0.0%+11.9%0.213% 5/15/2025 MPM Bioimpact LLC2,295,924$6.02M1.0%+1.2%1.339% 5/15/2025 PDT Partners LLC53,637$141K0.0%-50.6%0.031% 5/15/2025 DRW Securities LLC10,757$28K0.0%N/A0.006% 5/15/2025 Tema Etfs LLC89,110$233K0.1%+37.8%0.052% 5/15/2025 Trexquant Investment LP324,469$850K0.0%-66.8%0.189% 5/15/2025 OMERS ADMINISTRATION Corp85,200$223K0.0%N/A0.050% 5/14/2025 Ieq Capital LLC56,334$148K0.0%N/A0.033% 5/14/2025 Rafferty Asset Management LLC205,068$537K0.0%-17.8%0.120% 5/14/2025 MetLife Investment Management LLC65,272$171K0.0%-12.0%0.038% 5/14/2025 Walleye Capital LLC101,548$266K0.0%-89.0%0.059% 5/14/2025 CW Advisors LLC186,063$487K0.0%N/A0.109% 5/14/2025 Candriam S.C.A.580,136$1.52M0.0%-66.5%0.338% 5/14/2025 EntryPoint Capital LLC71,486$187K0.1%+220.2%0.042% 5/14/2025 Hsbc Holdings PLC116,408$300K0.0%+4.2%0.068% Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged.5/13/2025 Algert Global LLC931,251$2.44M0.1%-6.4%0.543% 5/13/2025 Cresset Asset Management LLC29,379$77K0.0%N/A0.017% 5/13/2025 American Century Companies Inc.308,752$809K0.0%+13.4%0.180% 5/13/2025 Russell Investments Group Ltd.39,519$104K0.0%-50.5%0.023% 5/13/2025 HighTower Advisors LLC247,176$648K0.0%+23.7%0.144% 5/12/2025 Nuveen LLC320,395$839K0.0%N/A0.187% 5/12/2025 Invesco Ltd.184,831$484K0.0%+54.8%0.108% 5/12/2025 Swiss National Bank227,000$595K0.0%+3.4%0.132% 5/9/2025 Deutsche Bank AG70,769$185K0.0%-14.2%0.041% 5/9/2025 Charles Schwab Investment Management Inc.1,064,858$2.79M0.0%+5.3%0.621% (Data available from 1/1/2016 forward) RLAY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RLAY shares? During the previous two years, 207 institutional investors and hedge funds held shares of Relay Therapeutics. The most heavily invested institutionals were Commodore Capital LP ($46.19M), BVF Inc. IL ($43.71M), Casdin Capital LLC ($36.87M), Tang Capital Management LLC ($33.24M), Vanguard Group Inc. ($31.72M), State Street Corp ($30.45M), and Bellevue Group AG ($28.48M).Learn more on Relay Therapeutics' institutional investors. What percentage of Relay Therapeutics' stock is owned by institutional investors? 96.98% of Relay Therapeutics' stock is owned by institutional investors. Learn more on RLAY's institutional investor holdings. Which institutional investors have been buying Relay Therapeutics' stock? Of the 180 institutional investors that purchased Relay Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Commodore Capital LP ($13.35M), Norges Bank ($9.69M), Tang Capital Management LLC ($4.50M), Bellevue Group AG ($2.90M), Millennium Management LLC ($2.80M), Eventide Asset Management LLC ($2.68M), and Vanguard Group Inc. ($1.85M). How much institutional buying is happening at Relay Therapeutics? Institutional investors have bought a total of 61,753,136 shares in the last 24 months. This purchase volume represents approximately $283.78M in transactions. Which of Relay Therapeutics' major shareholders have been selling company stock? Of the 57 institutional investors that sold Relay Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vanguard Group Inc. ($2.92M), Price T Rowe Associates Inc. MD ($1.96M), Walleye Capital LLC ($1.72M), Marshall Wace LLP ($1.38M), Franklin Resources Inc. ($1.34M), Goldman Sachs Group Inc. ($1.26M), and Candriam S.C.A. ($1.15M). How much institutional selling is happening at Relay Therapeutics? Institutional investors have sold a total of 18,324,779 shares in the last 24 months. This volume of shares sold represents approximately $64.51M in transactions. Related Companies CNTA Major Shareholders TARS Major Shareholders IBRX Major Shareholders AGIO Major Shareholders IDYA Major Shareholders DNLI Major Shareholders OCUL Major Shareholders HRMY Major Shareholders BLTE Major Shareholders SRPT Major Shareholders This page (NASDAQ:RLAY) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access